Athersys
ATHX
#11224
Rank
NZ$1.48 M
Marketcap
NZ$0.02406
Share price
-33.50%
Change (1 day)
-98.88%
Change (1 year)

Athersys (ATHX) - Cash on Hand

Cash on Hand as of September 2023 : NZ$1.81 Million

According to Athersys's latest financial reports the company has NZ$1.81 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Athersys - Cash on Hand chart (from 2006 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$14.23 M-74.01%
2021-12-31NZ$54.76 M-23.34%
2020-12-31NZ$71.43 M37.3%
2019-12-31NZ$52.02 M-31.65%
2018-12-31NZ$76.11 M84.41%
2017-12-31NZ$41.27 M93.81%
2016-12-31NZ$21.29 M-36.7%
2015-12-31NZ$33.64 M0.9%
2014-12-31NZ$33.34 M-14.23%
2013-12-31NZ$38.87 M25.26%
2012-12-31NZ$31.03 M89.49%
2011-12-31NZ$16.38 M-16.76%
2010-12-31NZ$19.67 M-32.91%
2009-12-31NZ$29.32 M-39.24%
2008-12-31NZ$48.27 M3.5%
2007-12-31NZ$46.63 M
2003-12-31NZ$29.08 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$36.98 B 2,034,998.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.84 B 1,146,762.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.92 B 1,371,370.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.91 B 710,434.31%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$12.72 B 699,998.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$19.72 B 1,084,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
NZ$0.71 B 39,374.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ$9.15 B 503,625.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA